|
|
||||||||
Vascular and Interventional Radiology |
1 From the Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, I-56125 Pisa, Italy (R.A.L., D.C., L.C., C.B.); and the Departments of Medicine II (H.P.A., P.D., H.F., I.Z., H.E.B.), Medical Biometry (M.O.), and Radiology (J.L.), University Hospital Freiburg, Germany. From the 2001 RSNA scientific assembly. Received June 17, 2002; revision requested August 8; final revision received November 26; accepted December 19. Address correspondence to R.A.L. (e-mail: lencioni@do.med.unipi.it).
PURPOSE: To compare the effectiveness of radio-frequency (RF) thermal ablation with that of percutaneous ethanol injection (PEI) for the treatment of small hepatocellular carcinoma (HCC) in patients with cirrhosis.
MATERIALS AND METHODS: A series of 102 patients with hepatic cirrhosis and either single HCC 5 cm in diameter or smaller or as many as three HCCs each 3 cm or smaller (overall number of lesions, 142) randomly received either RF ablation (n = 52) or PEI (n = 50) as the sole first-line anticancer treatment. Mean follow-up was 22.9 months ± 9.4 (SD) in the RF group and 22.4 months ± 8.6 in the PEI group. Prognostic value of treatment techniques was assessed with univariate and multivariate Cox proportional hazards regression models.
RESULTS: One- and 2-year survival rates were 100% and 98% in the RF group and 96% and 88% in the PEI group, respectively (univariate relative risk [RR] = 0.20; 95% CI: 0.02, 1.69; P = .138). One- and 2-year local recurrence-free survival rates were 98% and 96% in the RF group and 83% and 62% in the PEI group, respectively (univariate RR = 0.17; 95% CI: 0.06, 0.51; P = .002). One- and 2-year event-free survival rates were 86% and 64% for the RF group and 77% and 43% for the PEI group, respectively (univariate RR = 0.48; 95% CI: 0.27, 0.85; P = .012). RF treatment was confirmed as an independent prognostic factor for local recurrence-free survival rates with multivariate analysis (adjusted RR = 0.20; 95% CI: 0.05, 0.73; P = .015).
CONCLUSION: RF ablation is superior to PEI with respect to local recurrence-free survival rates.
© RSNA, 2003
Index terms: Alcohol ablation, 761.1266 Liver, cirrhosis, 76.794 Liver, interventional procedures, 761.1266, 761.1269 Liver neoplasms, 76.323 Radiofrequency (RF) ablation, 761.1269
This article has been cited by other articles:
![]() |
K. E. Corey and D. S. Pratt Review: Current status of therapy for hepatocellular carcinoma Therapeutic Advances in Gastroenterology, January 1, 2009; 2(1): 45 - 57. [Abstract] [PDF] |
||||
![]() |
E. Berber and A. Siperstein Local Recurrence After Laparoscopic Radiofrequency Ablation of Liver Tumors: An Analysis of 1032 Tumors Ann. Surg. Oncol., October 1, 2008; 15(10): 2757 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. de Baere, F. Deschamps, P. Briggs, C. Dromain, V. Boige, L. Hechelhammer, M. Abdel-Rehim, A. Auperin, D. Goere, and D. Elias Hepatic Malignancies: Percutaneous Radiofrequency Ablation during Percutaneous Portal or Hepatic Vein Occlusion Radiology, September 1, 2008; 248(3): 1056 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kei, H. Rhim, D. Choi, W. J. Lee, H. K. Lim, and Y.-s. Kim Local Tumor Progression After Radiofrequency Ablation of Liver Tumors: Analysis of Morphologic Pattern and Site of Recurrence Am. J. Roentgenol., June 1, 2008; 190(6): 1544 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rhim, M. H. Lee, Y.-s. Kim, D. Choi, W. J. Lee, and H. K. Lim Planning Sonography to Assess the Feasibility of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas Am. J. Roentgenol., May 1, 2008; 190(5): 1324 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Belghiti, B. I. Carr, P. D. Greig, R. Lencioni, and R. T. Poon Treatment before Liver Transplantation for HCC Ann. Surg. Oncol., April 1, 2008; 15(4): 993 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamakado, A. Nakatsuka, H. Takaki, H. Yokoi, M. Usui, H. Sakurai, S. Isaji, K. Shiraki, H. Fuke, S. Uemoto, et al. Early-Stage Hepatocellular Carcinoma: Radiofrequency Ablation Combined with Chemoembolization versus Hepatectomy Radiology, April 1, 2008; 247(1): 260 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Wong, C.-J. Lin, C.-C. Lin, W.-T. Chen, I. H. Y. Cua, and S.-M. Lin Combined Percutaneous Radiofrequency Ablation and Ethanol Injection for Hepatocellular Carcinoma in High-Risk Locations Am. J. Roentgenol., March 1, 2008; 190(3): W187 - W195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-h. Park, H. Rhim, Y.-s. Kim, D. Choi, H. K. Lim, and W. J. Lee Spectrum of CT Findings after Radiofrequency Ablation of Hepatic Tumors RadioGraphics, March 1, 2008; 28(2): 379 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rhim, H. K. Lim, Y.-s. Kim, and D. Choi Percutaneous Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in the Hepatic Dome: Initial Experience Am. J. Roentgenol., January 1, 2008; 190(1): 91 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shao, J. Bai, L. Cui, J. Wang, Y. Fu, K. Liu, and S. Feng Elastographic Evaluation of the Temporal Formation of Ethanol-Induced Hepatic Lesions: Preliminary In Vitro Results J. Ultrasound Med., September 1, 2007; 26(9): 1191 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Choi, H. K. Lim, H. Rhim, Y.-s. Kim, B. C. Yoo, S. W. Paik, J.-W. Joh, and C. K. Park Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors Ann. Surg. Oncol., August 1, 2007; 14(8): 2319 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Zhang, H.-H. Liang, M.-S. Chen, R.-P. Guo, J.-Q. Li, Y. Zheng, Y.-Q. Zhang, and W. Y. Lau Hepatocellular Carcinoma Treated with Radiofrequency Ablation with or without Ethanol Injection: A Prospective Randomized Trial Radiology, August 1, 2007; 244(2): 599 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Laeseke, T. M. Frey, C. L. Brace, L. A. Sampson, T. C. Winter III, J. R. Ketzler, and F. T. Lee Jr. Multiple-Electrode Radiofrequency Ablation of Hepatic Malignancies: Initial Clinical Experience Am. J. Roentgenol., June 1, 2007; 188(6): 1485 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Chiou, J.-B. Liu, and L. Needleman Current Status of Sonographically Guided Radiofrequency Ablation Techniques J. Ultrasound Med., April 1, 2007; 26(4): 487 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Maher, P. A. Hodnett, and M. K. Kalra Evidence-based Practice in Radiology: Steps 3 and 4--Appraise and Apply Interventional Radiology Literature Radiology, March 1, 2007; 242(3): 658 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakazawa, S. Kokubu, A. Shibuya, K. Ono, M. Watanabe, H. Hidaka, T. Tsuchihashi, and K. Saigenji Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin Am. J. Roentgenol., February 1, 2007; 188(2): 480 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Laeseke, L. A. Sampson, D. Haemmerich, C. L. Brace, J. P. Fine, T. M. Frey, T. C. Winter III, and F. T. Lee Jr Multiple-Electrode Radiofrequency Ablation Creates Confluent Areas of Necrosis: In Vivo Porcine Liver Results Radiology, October 1, 2006; 241(1): 116 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. d. Baere, J. Palussiere, A. Auperin, A. Hakime, M. Abdel-Rehim, M. Kind, C. Dromain, A. Ravaud, N. Tebboune, V. Boige, et al. Midterm Local Efficacy and Survival after Radiofrequency Ablation of Lung Tumors with Minimum Follow-up of 1 Year: Prospective Evaluation. Radiology, August 1, 2006; 240(2): 587 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shibuya, T. Nakazawa, K. Saigenji, K. Furuta, and K. Matsunaga Diaphragmatic hernia after radiofrequency ablation therapy for hepatocellular carcinoma. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S241 - S243. [Full Text] [PDF] |
||||
![]() |
Y. K. Cho, H. Rhim, Y. S. Ahn, M. Y. Kim, and H. K. Lim Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S269 - S274. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Hinshaw, P. F. Laeseke, T. C. Winter III, M. A. Kliewer, J. P. Fine, and F. T. Lee Jr. Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S306 - S310. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Sutherland, J. A. R. Williams, R. T. A. Padbury, D. C. Gotley, B. Stokes, and G. J. Maddern Radiofrequency ablation of liver tumors: a systematic review. Arch Surg, February 1, 2006; 141(2): 181 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zerbini, M. Pilli, A. Penna, G. Pelosi, C. Schianchi, A. Molinari, S. Schivazappa, C. Zibera, F. F. Fagnoni, C. Ferrari, et al. Radiofrequency Thermal Ablation of Hepatocellular Carcinoma Liver Nodules Can Activate and Enhance Tumor-Specific T-Cell Responses Cancer Res., January 15, 2006; 66(2): 1139 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shibata, T. Shibata, Y. Maetani, H. Isoda, and M. Hiraoka Radiofrequency Ablation for Small Hepatocellular Carcinoma: Prospective Comparison of Internally Cooled Electrode and Expandable Electrode Radiology, January 1, 2006; 238(1): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Staunton, J. D. Dodd, P. A. McCormick, and D. E. Malone Finding Evidence-based Answers to Practical Questions in Radiology: Which Patients with Inoperable Hepatocellular Carcinoma Will Survive Longer after Transarterial Chemoembolization? Radiology, November 1, 2005; 237(2): 404 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S-M Lin, C-J Lin, C-C Lin, C-W Hsu, and Y-C Chen Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less Gut, August 1, 2005; 54(8): 1151 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Tanabe, L. S. Blaszkowsky, R. T. Chung, M. A. Blake, and G. Y. Lauwers Case 23-2005 - A 57-Year-Old Man with a Mass in the Liver N. Engl. J. Med., July 28, 2005; 353(4): 401 - 410. [Full Text] [PDF] |
||||
![]() |
D. Choi, H. K. Lim, M. J. Kim, S. J. Kim, S. H. Kim, W. J. Lee, J. H. Lim, S. W. Paik, B. C. Yoo, M. S. Choi, et al. Liver Abscess After Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Frequency and Risk Factors Am. J. Roentgenol., June 1, 2005; 184(6): 1860 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawashima, J. Furuse, T. Nishio, M. Konishi, H. Ishii, T. Kinoshita, M. Nagase, K. Nihei, and T. Ogino Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular Carcinoma J. Clin. Oncol., March 20, 2005; 23(9): 1839 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lencioni, D. Cioni, L. Crocetti, C. Franchini, C. D. Pina, J. Lera, and C. Bartolozzi Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency Ablation Radiology, March 1, 2005; 234(3): 961 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lee, J. K. Han, S. H. Kim, S. H. Choi, S. K. An, C. J. Han, and B. I. Choi Bipolar Radiofrequency Ablation Using Wet-Cooled Electrodes: An In Vitro Experimental Study in Bovine Liver Am. J. Roentgenol., February 1, 2005; 184(2): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giorgio, L. Tarantino, G. de Stefano, C. Coppola, and G. Ferraioli Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single Center Am. J. Roentgenol., January 1, 2005; 184(1): 207 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Seror, G. N'Kontchou, D. Haddar, M. Dordea, Y. Ajavon, N. Ganne, J. C. Trinchet, M. Beaugrand, and N. Sellier Large Infiltrative Hepatocellular Carcinomas: Treatment with Percutaneous Intraarterial Ethanol Injection Alone or in Combination with Conventional Percutaneous Ethanol Injection Radiology, January 1, 2005; 234(1): 299 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. Stolberg, G. Norman, and I. Trop Randomized Controlled Trials Am. J. Roentgenol., December 1, 2004; 183(6): 1539 - 1544. [Full Text] [PDF] |
||||
![]() |
J M Lee, J K Han, S H Kim, J Y Lee, S H Choi, and B I Choi Hepatic bipolar radiofrequency ablation using perfused-cooled electrodes: a comparative study in the ex vivo bovine liver Br. J. Radiol., November 1, 2004; 77(923): 944 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Choi, H. K. Lim, M. J. Kim, S. H. Kim, W. J. Lee, S. H. Kim, J. H. Lim, S. W. Paik, K. C. Koh, and B. C. Yoo Therapeutic Efficacy and Safety of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma Abutting the Gastrointestinal Tract Am. J. Roentgenol., November 1, 2004; 183(5): 1417 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A Guthrie Cirrhosis and focal liver lesions: MRI findings Imaging, September 1, 2004; 16(4): 351 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Breuhahn, S. Vreden, R. Haddad, S. Beckebaum, D. Stippel, P. Flemming, T. Nussbaum, W. H. Caselmann, B. B. Haab, and P. Schirmacher Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression Cancer Res., September 1, 2004; 64(17): 6058 - 6064. [Abstract] [Full Text] [PDF] |
||||
![]() |
A R Gillams Liver ablation therapy Br. J. Radiol., September 1, 2004; 77(921): 713 - 723. [Full Text] [PDF] |
||||
![]() |
A. Giorgio, G. Ferraioli, and R. A. Lencioni Radiofrequency Thermal Ablation versus Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma [letter] * Dr Lencioni and colleagues respond: Radiology, March 1, 2004; 230(3): 886 - 887. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |